MIRA INFORM REPORT
|
Report No. : |
343127 |
|
Report Date : |
02.10.2015 |
IDENTIFICATION DETAILS
|
Name : |
SERUM INSTITUTE OF INDIA LIMITED |
|
|
|
|
Registered
Office : |
212/2, Off Soli Poonawalla Road, Hadapsar, Pune – 411028, Maharashtra |
|
Tel. No.: |
91-20-26993900/ 26993904 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2014 |
|
|
|
|
Date of
Incorporation : |
22.05.1984 |
|
|
|
|
Com. Reg. No.: |
11-032945 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.48.193 Million |
|
|
|
|
IEC No.: |
0388093145 |
|
|
|
|
CIN No.: [Company Identification
No.] |
U80903PN1984PLC032945 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
PNES15736A PNES00023C |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCS4225M |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer,
Exporter and Importer of Vaccines and Immuno. |
|
|
|
|
No. of Employees
: |
Information declined by the management |
RATING & COMMENTS
|
MIRA’s Rating : |
Aa (77) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exists |
|
|
|
|
Comments : |
Subject is a subsidiary of “Poonawalla Investments and Industries
Private Limited”. It is an established company incorporated in the year 1984
having excellent track. Serum Institute of India Limited is a manufacturer of immunobiological
drugs including vaccines in India. The company is managed by Poonawalla
group. It is the world’s largest vaccine producer. Available financial indicates company strong financial risk profile
characterized by robust revenue growth, healthy operating margins, low gearing
levels and healthy liquidity position. The rating further takes into consideration rich experience of the
promoters, professionally-qualified management, long-standing affiliations
with international agencies and established track of the company. Trade relations are reported as trustworthy. Business is active.
Payments are reported as regular and as per commitments. In view of the aforesaid, the company can be considered excellent for
business dealings at usual trade terms and condition. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CARE |
|
Rating |
Long Term Bank Facilities=AAA |
|
Rating Explanation |
Highest degree of safety and carry lowest credit risk. |
|
Date |
16.04.2015 |
|
Rating Agency Name |
CARE |
|
Rating |
Short Term, Bank Facilities=A1+ |
|
Rating Explanation |
Very strong degree of safety and carry lowest credit risk. |
|
Date |
16.04.2015 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2015.
INFORMATION DENIED BY
|
Name : |
Mr. Dilip Londhe |
|
Designation : |
Finance Department |
|
Contact No.: |
91-20-26100403 |
|
Date : |
28.09.2015 |
|
|
|
|
Name : |
Mr. Pradeep |
|
Designation : |
Office Executive |
|
Contact No.: |
91-20-26993900 |
LOCATIONS
|
Registered Office / Human Resources / International Marketing Division
: |
212/2, Off Soli Poonawalla Road, Hadapsar, Pune – 411028, Maharashtra,
India |
|
Tel. No.: |
91-20-26993900/ 26993904 |
|
Fax No.: |
91-20-26993921/ 26133228 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
Owned |
|
Location : |
Commercial |
|
|
|
|
Domestic Marketing Division : |
501, Dalamal Tower, 211, Nariman Point, Mumbai – 400021, Maharashtra,
India |
|
Tel. No.: |
91-22-22840370 |
|
Fax No.: |
91-22-22044389 |
|
E-Mail : |
|
|
|
|
|
Finance Division: |
Sarosh Bhavan, 16-B/1, Dr. Ambedkar Road, Pune – 411001, Maharashtra,
India |
|
Tel. No.: |
91-20-26137221 / 226 |
|
Fax No.: |
91-20-26133228 |
|
E-Mail : |
|
|
|
|
|
Administrative Office : |
Mittal Court, 3rd Floor, A Wing, Dr. Ambedkar Road, Pune – 411001, Maharashtra, India |
|
|
|
|
Branch Office : |
Located at: · Chennai · Kolkata ·
·
·
Vishakapatnam ·
Trivandrum |
DIRECTORS
As on 04.09.2014
|
Name : |
Mr. Adar Cyrus Poonawalla |
|
Designation : |
Whole Time Director |
|
Address : |
11, Poonawalla Park, Pune – 411037, Maharashtra, India |
|
Date of Birth/Age : |
14.01.1981 |
|
Qualification : |
B.B.A.(Finance) UK |
|
Date of Appointment : |
01.04.2014 |
|
PAN No.: |
AFEPP9955N |
|
DIN No.: |
00044815 |
|
|
|
|
Name : |
Mr. Behroze Zavareh Poonawalla |
|
Designation : |
Director |
|
Address : |
12, Poonawalla Park, Pune – 411037, Maharashtra, India |
|
Date of Birth/Age : |
08.12.1946 |
|
Qualification : |
B.A. |
|
Date of Appointment : |
01.02.1986 |
|
DIN No.: |
00044877 |
|
|
|
|
Name : |
Dr. Cyrus Soli Poonawalla |
|
Designation : |
Chairman cum Managing Director |
|
Address : |
11, Poonawalla Park, Pune – 411 037, Maharashtra, India |
|
Date of Birth/Age : |
11.05.1941 |
|
Date of Appointment : |
01.07.2012 |
|
PAN No.: |
AAXPP9204A |
|
DIN No.: |
00044650 |
|
|
|
|
Name : |
Dr. (Mrs.) Mrudula Arvind Phadke |
|
Designation : |
Director |
|
Address : |
181, Buena Vista Society, Jagannath Bhosale Marg, Near Mantralaya, Mumbai – 400021, Maharashtra, India |
|
Date of Birth/Age : |
22.12.1944 |
|
Qualification : |
M.D., D.C.H. |
|
Date of Appointment : |
25.08.2008 |
|
DIN No: |
01959083 |
|
|
|
|
Name : |
Dr. Rajeev Mhalasakant Dhere |
|
Designation : |
Whole Time Director |
|
Address : |
Flat No. 3, Mahalaxmi Niwas, 146, Shaniwar Peth, Pune – 411030, Maharashtra, India |
|
Date of Birth/Age : |
11.11.1954 |
|
Date of Appointment : |
07.08.2012 |
|
DIN No: |
05174953 |
|
|
|
|
Name : |
Dr. Satish Damodar Ravetkar |
|
Designation : |
Whole Time Director |
|
Address : |
4, Sadashanti Apartments, Prabhat Road, Lane No 9a, Pune - 411004, Maharashtra, India |
|
Date of Birth/Age : |
14.07.1951 |
|
Date of Appointment : |
07.08.2012 |
|
DIN No: |
05175036 |
|
|
|
|
Name : |
Mr. Satish Ramchandra Mundra |
|
Designation : |
Whole Time Director |
|
Address : |
401, Clover Court, Opposite Guruprasad Society, Pune – 411001, Maharashtra, India |
|
Date of Birth/Age : |
04.06.1943 |
|
Qualification : |
M.Com. |
|
Date of Appointment : |
01.04.2013 |
|
PAN No.: |
ABFPM7101E |
|
DIN No.: |
00416654 |
|
|
|
|
Name : |
Dr. Suresh Sahkaram Jadhav |
|
Designation : |
Whole Time Director |
|
Address : |
16, Sadhana Society, Near Akashwani, Pune – 411028, Maharashtra, India |
|
Date of Birth/Age : |
24.01.1950 |
|
Qualification : |
M. Pharm, Ph D |
|
Date of Appointment : |
01.04.2014 |
|
PAN No.: |
ABAPJ9475D |
|
DIN No.: |
00056701 |
|
|
|
|
Name : |
Mr. Zavareh Soli Poonawalla |
|
Designation : |
Director |
|
Address : |
12, Poonawalla Park, Pune – 411 037, Maharashtra, India |
|
Date of Birth/Age : |
04.12.1943 |
|
Date of Appointment: |
01.07.2007 |
|
PAN No.: |
AAJPP5268N |
|
DIN No.: |
00044760 |
KEY EXECUTIVES
|
Name : |
Mr. Makarand Shrikrishna Karkare |
|
Designation : |
Company Secretary |
|
Address : |
A 507, Shilpa Housing Society, 124/ 15A/ 2, Off |
|
Date of Birth/Age : |
30.05.1963 |
|
Date of Appointment : |
08.06.2006 |
|
PAN No.: |
ACDPK4983F |
|
|
|
|
Name : |
Mr. Adar Cyrus Poonawalla |
|
Designation : |
Chief Executive Officer |
|
|
|
|
Name : |
Mr. Dilip Londhe |
|
Designation : |
Finance Department |
|
|
|
|
Name : |
Mr. Pradeep |
|
Designation : |
Office Executive |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 04.09.2014
|
Names of Shareholders |
No. of Shares |
|
Poonawalla Investments and Industries Private Limited, |
3244617 |
|
Adar Cyrus Poonwawalla |
249808 |
|
Cyrus Soli Poonwalla |
493578 |
|
Corpint Investments Private Limited, |
40 |
|
Fortune Intercontinental Private Limited, |
40 |
|
Zavareh Soli Poonawalla |
240963 |
|
Adar Cyrus Poonwawalla |
557600 |
|
Chanda Investments and Trading Company Private Limited, |
40 |
|
Adurjee and Bros Private Limited, India |
32567 |
|
Total |
4819253 |
Equity Share Break up (Percentage of Total Equity)
As on 04.09.2014
|
Category |
Percentage of Holding |
|
Bodies corporate |
68.00 |
|
Directors or relatives of Directors |
32.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer,
Exporter and Importer of Vaccines and Immuno. |
||||||
|
|
|
||||||
|
Products : |
|
||||||
|
|
|
||||||
|
Brand Names : |
Not Available |
||||||
|
|
|
||||||
|
Agencies Held : |
Not Available |
||||||
|
|
|
||||||
|
Exports : |
Not Divulged |
||||||
|
|
|
||||||
|
Imports : |
Not Divulged |
||||||
|
|
|
||||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
No. of Employees : |
Information declined by the management |
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
Patki and Soman Chartered Accountants |
|
Address : |
101/102, Parmesh Plaza, Pune - 411030, Maharashtra, India |
|
PAN
No. : |
AACFP3742Q |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Holding Company : |
|
|
|
|
|
Others : |
|
|
|
|
|
Subsidiary Company
: |
|
CAPITAL STRUCTURE
As on 04.09.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
54750000 |
Equity Shares |
Rs.10/- each |
Rs.547.500 Million |
|
250000 |
Preference Shares |
Rs.10/- each |
Rs.2.500 Million |
|
|
Total |
|
Rs.550.000
Million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
4819253 |
Equity Shares |
Rs.10/- each |
Rs.48.193 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders'
Funds |
|
|
|
|
(a) Share Capital |
48.192 |
48.193 |
48.193 |
|
(b) Reserves & Surplus |
59212.757 |
41700.360 |
27532.242 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2)
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
59260.949 |
41748.552 |
27580.434 |
|
|
|
|
|
|
(3) Non-Current
Liabilities |
|
|
|
|
(a) long-term borrowings |
673.324 |
1248.139 |
1985.789 |
|
(b) Deferred tax liabilities (Net) |
148.505 |
0.000 |
0.000 |
|
(c) Other long term
liabilities |
303.650 |
138.538 |
129.752 |
|
(d) long-term
provisions |
0.000 |
315.682 |
353.087 |
|
Total Non-current
Liabilities (3) |
1125.479 |
1702.359 |
2468.628 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
5158.567 |
4526.074 |
4207.055 |
|
(b) Trade
payables |
543.328 |
674.700 |
420.094 |
|
(c) Other
current liabilities |
818.992 |
842.913 |
909.875 |
|
(d) Short-term provisions |
12766.123 |
7921.305 |
6166.983 |
|
Total Current
Liabilities (4) |
19287.010 |
13964.992 |
11704.007 |
|
|
|
|
|
|
TOTAL |
79673.438 |
57415.903 |
41753.069 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
12538.070 |
9108.120 |
8335.940 |
|
(ii)
Intangible Assets |
228.518 |
57.580 |
91.832 |
|
(iii)
Capital work-in-progress |
2134.922 |
2068.269 |
990.616 |
|
(iv)
Intangible assets under development |
1752.579 |
1414.810 |
915.414 |
|
(b) Non-current Investments |
30288.470 |
20254.847 |
17155.359 |
|
(c) Deferred tax assets (net) |
4804.006 |
2877.607 |
1325.873 |
|
(d) Long-term Loan and Advances |
125.947 |
156.631 |
96.634 |
|
(e) Other Non-current
assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current
Assets |
51872.512 |
35937.864 |
28911.668 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
7250.670 |
5939.077 |
4120.390 |
|
(c) Trade
receivables |
4317.412 |
3797.988 |
2867.975 |
|
(d) Cash
and cash equivalents |
2586.879 |
569.484 |
480.800 |
|
(e)
Short-term loans and advances |
12730.821 |
10682.759 |
5101.191 |
|
(f) Other
current assets |
915.144 |
488.731 |
271.045 |
|
Total
Current Assets |
27800.926 |
21478.039 |
12841.401 |
|
|
|
|
|
|
TOTAL |
79673.438 |
57415.903 |
41753.069 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
35437.464 |
25241.414 |
17148.277 |
|
|
|
Other Income |
924.608 |
636.933 |
525.674 |
|
|
|
TOTAL |
36362.072 |
25878.347 |
17673.951 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
5214.465 |
3189.676 |
2081.692 |
|
|
|
Changes in inventories of finished goods, work-in-progress
and Stock-in-Trade |
(524.595) |
(1102.100) |
(452.479) |
|
|
|
Employees benefits expense |
4548.329 |
3254.858 |
2622.939 |
|
|
|
Other expenses |
5808.923 |
4947.482 |
2879.983 |
|
|
|
TOTAL |
15047.122 |
10289.916 |
7132.135 |
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
21314.950 |
15588.432 |
10541.816 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
245.440 |
330.937 |
242.699 |
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
21069.510 |
15257.495 |
10299.117 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
1511.791 |
1196.983 |
1089.406 |
|
|
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE TAX |
19557.719 |
14060.511 |
9209.711 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
2144.399 |
1107.35 |
928.898 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
17413.320 |
12953.161 |
8280.813 |
|
|
|
|
|
|
|
|
|
|
Earnings / (Loss)
Per Share (Rs.) |
3613.28 |
2662.00 |
1718.00 |
|
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Current Maturities of Long term debt |
NA |
75.500 |
726.714 |
|
Cash generated from operations |
NA |
NA |
NA |
|
Net cash flow from operating activity |
NA |
6691.862 |
8573.930 |
KEY
RATIOS
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Net Profit Margin (PAT/Sales) |
(%) |
49.14 |
51.32 |
48.29 |
|
|
|
|
|
|
|
Operating Profit Margin (PBIDT/Sales) |
(%) |
60.15 |
61.76 |
61.47 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
48.06 |
45.65 |
43.10 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.33 |
0.34 |
0.33 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.10 |
0.14 |
0.22 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.44 |
1.54 |
1.10 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Share Capital |
48.193 |
48.193 |
48.192 |
|
Reserves & Surplus |
27532.242 |
41700.360 |
59212.757 |
|
Net
worth |
27580.435 |
41748.553 |
59260.949 |
|
long-term borrowings |
1985.789 |
1248.139 |
673.324 |
|
Short term borrowings |
4207.055 |
4526.074 |
5158.567 |
|
Total
borrowings |
6192.844 |
5774.213 |
5831.891 |
|
Debt/Equity
ratio |
0.225 |
0.138 |
0.098 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Sales |
17148.277 |
25241.414 |
35437.464 |
|
|
|
47.195 |
40.394 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Sales |
17148.277 |
25241.414 |
35437.464 |
|
Profit |
8280.813 |
12953.161 |
17413.320 |
|
|
48.29% |
51.32% |
49.14% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
Yes |
|
32 |
Litigations that the firm/promoter
involved in |
Yes |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
LITIGATION
DETAILS:
|
Case Details Bench:- Bombay |
||||
|
Lodging No. : |
ITXAL/1353/2015 |
Failing Date:- |
11/09/2015 |
|
|
Petitioner:- |
THE COMMISSIONER OF INCOME TAX |
Respondent:- |
SERUM INSTITUTE OF INDIA LIMITED |
|
|
Petn.Adv:- |
TEJVEER SINGH MASTAN SINGH (I3678) |
|||
|
District:- |
MUMBAI |
|||
|
Bench:- |
DIVISION |
Category:- |
TAX APPEALS |
|
|
Status:- |
Pre-Admission |
Stage:- |
||
|
Last Date:- |
21/09/2015 |
|||
|
Last Coram:- |
REGISTRAR (OS) / PROTHONOTARY AND SR. MASTER. |
|||
|
|
|
|||
|
Act. : |
Income Tax Act,1961 |
Under Section 260A |
||
UNSECURED LOAN
|
PARTICULAR |
31.03.2014 (Rs.
In Million) |
31.03.2013 (Rs.
In Million) |
|
SHORT TERM
BORROWINGS |
|
|
|
Rupee term loan from others |
NA |
298.702 |
|
Rupee term loan from bank |
NA |
4021.291 |
|
Deposits from directors |
NA |
206.081 |
|
Total |
NA |
4526.074 |
INDEX
OF CHARGES
|
S.No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
10140096 |
31/12/2008 |
2,442,530,000.00 |
CITIBANK N. A. |
CITIBANK CENTER,
BANDRA KURLA COMPLEX, BANDRA EAST, PUNE, Maharashtra - 400051, INDIA |
A54694658 |
OTHER ACHIEVEMENTS
RANKING AS NO 1
BIOTECH COMPANY IN INDIA
The Company
continues to retain the trend of being ranked as No. 1 Biotech Company for
2012-13, in India.
PRODUCT OF THE
YEAR AWARD
The Men AfriVac Vaccine
manufactured by the Company was awarded with the Bio Spectrum Asia Pacific
Product of the Year 2013 Award. This vaccine has enabled the UNICEF to address
the meningitis epidemic in sub-Saharan Africa.
BIO EXCELLENCE
AWARD
The Company has
been awarded the Bio-Excellence Award under the category - Bio Pharma and
Healthcare, during the Bangalore India Bio 2013, India’s leading Biotech Event,
organized by the Department of Information Technology, Biotechnology and
Science and Technology Government of Karnataka.
The Company highly
appreciates the national and international recognitions and honor’s bestowed
upon it and places its gratitude’s to all the institutions and health
organizations.
FIXED ASSETS
- Land
- Buildings
- Plant and Equipment
- Furniture and Fixtures
- Vehicles
- Aircrafts Helicopters
- Office Equipment
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.65.55 |
|
|
1 |
Rs.99.17 |
|
Euro |
1 |
Rs.73.07 |
INFORMATION DETAILS
|
Information
Gathered by : |
NYA |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
SUD |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
8 |
|
PAID-UP CAPITAL |
1~10 |
8 |
|
OPERATING SCALE |
1~10 |
9 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
9 |
|
--PROFITABILITY |
1~10 |
8 |
|
--LIQUIDITY |
1~10 |
8 |
|
--LEVERAGE |
1~10 |
8 |
|
--RESERVES |
1~10 |
10 |
|
--CREDIT LINES |
1~10 |
9 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
NO |
|
DEFAULTER
|
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
77 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.